Related Experiment Video
Updated: Mar 27, 2026
05:53
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
10.8K
Comparison of different clinical development plans for confirmatory subpopulation selection
Kaspar Rufibach1, Meng Chen2, Hoa Nguyen3
1Department of Biostatistics, Hoffmann-La Roche Ltd., Basel, Switzerland.
Contemporary Clinical Trials
|January 9, 2016
Summary
Adaptive enrichment designs optimize drug development by identifying patient subgroups who benefit most from new therapies. This approach can accelerate timelines and reduce costs compared to traditional methods.
Area of Science:
- Clinical trial design
- Biomarker-driven drug development
- Pharmaceutical research
Background:
- Rising drug development costs and market competition necessitate innovative clinical trial strategies.
- Adaptive enrichment designs offer a flexible approach to identify patient subgroups with differential treatment benefits based on biomarkers.
Purpose of the Study:
- To compare three clinical development plans utilizing adaptive enrichment designs for time-to-event endpoints.
- To quantify the time advantage of adaptive enrichment Phase II/III designs over alternative development strategies.
- To define biomarker requirements for early-phase clinical trials within these designs.
Main Methods:
- Comparison of three distinct clinical development plans for a pivotal trial.
- Utilizing a fast time-to-event endpoint (e.g., progression-free survival) for interim analysis decisions.
- Evaluation of time gain and biomarker necessity for each development scenario.
Main Results:
- Adaptive enrichment designs can lead to significant time gains in drug development.
- The choice of development plan impacts decision-making regarding treatment efficacy in specific biomarker subgroups.
- Specific biomarker types are required prior to Phase II for successful implementation.
Conclusions:
- Adaptive enrichment designs are a valuable tool for optimizing drug development programs.
- These designs allow for tailored decision-making based on biomarker subgroup efficacy.
- Careful planning regarding biomarker availability is crucial for successful adaptive trial implementation.
Keywords:
Adaptive designBiomarkerCompanion diagnosticParallel trial strategySequential trial strategyp-Value combinationMore Related Videos
08:58Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
Published on: October 17, 2025
801
07:25In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
18.3K
Related Concept Videos
01:11Clinical Trials: Overview
5.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.4K
01:28Preclinical Development: Overview
6.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.4K
01:20Comparing the Survival Analysis of Two or More Groups
704
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
704
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
529
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
529
01:12Analysis of Population Pharmacokinetic Data
907
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
907
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
386
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
386